Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
Juan Carrillo-Reixach, Laura Torrens, Marina Simon‐Coma, Laura Royo, Montserrat Domingo-Sàbat, Jordi Abril‐Fornaguera, Nicholas K. Akers, María Sala, S. Ragull, Magdalena Arnal, Núria Villalmanzo, Stefano Cairo, Alberto Villanueva, Roland Kappler, Marta Garrido, Laura Guerra, Constantino Sábado, Gabriela Guillén, Mar Mallo, David Piñeyro, Maria Vázquez‐Vitali, Olga Kuchuk, María Elena Mateos, Gema Ramírez, Manuel Santamarı́a, Yasmina Mozo, Aroa Soriano, Michael Grotzer, Sophie Branchereau, Nagore García de Andoín, Blanca López‐Ibor, Ricardo López Almaraz, José Antonio Salinas, Bárbara Torres, F Hernández, José Javier Uriz, Monique Fabrè, Julià Blanco, Claudia Paris, Viera Bajčiová, Geneviève Laureys, Helena Masnou, Ariadna Clos, Cristina Beléndez, Catherine Guettier, Lauro Sumoy, Ramón Planas, Mireia Jordà, Lara Nonell, Piotr Czauderna, Bruce Morland, Daniela Sia, Bojan Losic, Marie Annick Buendia, Maria‐Rosa Sarrias, Josep M. Llovet, Carolina Armengol (2020). Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. Journal of Hepatology, 73(2), pp. 328-341, DOI: 10.1016/j.jhep.2020.03.025.
